Log in

NHMRC Centre for Blood Transplant and Cell Therapies Webinar 20 August 2020

18 Aug 2020 11:20 AM | Anonymous member (Administrator)

The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, investigators from the CBTCT will review major topics in stem cell transplantation and cell therapy, highlighting how the activities of the CBTCT are addressing current challenges in stem cell transplantation. Following on in this series, Professor David Curtis from the Alfred Hospital in Melbourne will review the role of post-transplant cyclophosphamide for the prevention of graft versus host disease following allogeneic blood transplant. Mr Mingdi Xie, who is the current MAGIC Australia Project coordinator for the CBTCT, will then present an introduction to the MAGIC consortium, including its functions and importance in allogeneic blood transplant research

Speakers:

Professor David Curtis – The Alfred Hospital and Monash University

Mr Mingdi Xie – The Royal Melbourne Hospital and Peter MacCallum Cancer Centre

When: Thursday 20 August 2020, 8am AEST

For more information and the link to the webinar click here

Website: bloodcelltherapy.org.au 


CONTACT

Haematology Society of Australia and New Zealand (HSANZ)
145 Macquarie Street, Sydney NSW 2000
Tel: 02 8097 8114


FOLLOW US

Copyright © 2020 Haematology Society of Australia & New Zealand (HSANZ). All Rights Reserved.

Powered by Wild Apricot Membership Software